GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Mesirow Financial Investment Management Inc.

Mesirow Financial Investment Management Inc. cut its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.7% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,891 shares of the company’s stock after selling 193 shares during the quarter. Mesirow Financial Investment Management Inc.’s holdings in GE HealthCare Technologies were worth $304,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Ashton Thomas Securities LLC acquired a new position in GE HealthCare Technologies during the third quarter worth $26,000. Capital Performance Advisors LLP acquired a new position in GE HealthCare Technologies during the third quarter worth $26,000. Darwin Wealth Management LLC acquired a new position in GE HealthCare Technologies during the third quarter worth $31,000. Continuum Advisory LLC raised its holdings in GE HealthCare Technologies by 101.8% during the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after purchasing an additional 168 shares during the last quarter. Finally, Bank of Jackson Hole Trust acquired a new position in GE HealthCare Technologies during the fourth quarter worth $32,000. 82.06% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

GEHC has been the subject of several research reports. Wells Fargo & Company lifted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Citigroup raised their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $97.67.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $86.58 on Monday. The company has a market cap of $39.59 billion, a P/E ratio of 20.00, a P/E/G ratio of 3.19 and a beta of 1.13. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80. The business has a fifty day simple moving average of $86.77 and a 200-day simple moving average of $86.16.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.